CROTTI, LIA
 Distribuzione geografica
Continente #
NA - Nord America 12.368
EU - Europa 6.708
AS - Asia 5.481
SA - Sud America 367
AF - Africa 58
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.031
Nazione #
US - Stati Uniti d'America 12.200
SG - Singapore 1.971
HK - Hong Kong 1.726
RU - Federazione Russa 1.620
IT - Italia 1.429
CN - Cina 1.134
IE - Irlanda 869
SE - Svezia 699
DE - Germania 682
GB - Regno Unito 377
BR - Brasile 279
ID - Indonesia 229
UA - Ucraina 216
FR - Francia 144
CA - Canada 127
NL - Olanda 108
AT - Austria 105
ES - Italia 105
JP - Giappone 81
FI - Finlandia 72
IN - India 71
VN - Vietnam 65
DK - Danimarca 61
KR - Corea 59
AR - Argentina 44
CH - Svizzera 39
BE - Belgio 38
MX - Messico 34
AU - Australia 31
TR - Turchia 29
GR - Grecia 25
PL - Polonia 25
PT - Portogallo 23
ZA - Sudafrica 19
CO - Colombia 18
RO - Romania 15
CL - Cile 13
LT - Lituania 11
NZ - Nuova Zelanda 11
BD - Bangladesh 10
IR - Iran 10
TW - Taiwan 10
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
IQ - Iraq 7
SC - Seychelles 7
HR - Croazia 6
MA - Marocco 6
RS - Serbia 6
SA - Arabia Saudita 6
TH - Thailandia 6
EC - Ecuador 5
KW - Kuwait 5
KZ - Kazakistan 5
MY - Malesia 5
NG - Nigeria 5
NO - Norvegia 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
UZ - Uzbekistan 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
EU - Europa 3
HU - Ungheria 3
KE - Kenya 3
LK - Sri Lanka 3
PK - Pakistan 3
SI - Slovenia 3
SN - Senegal 3
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
JO - Giordania 2
KG - Kirghizistan 2
MT - Malta 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
Totale 25.027
Città #
Hong Kong 1.702
Fairfield 1.558
Singapore 1.353
Ann Arbor 1.273
Dublin 817
Chandler 740
Ashburn 734
Woodbridge 698
Wilmington 674
Houston 597
Seattle 588
Santa Clara 507
Dearborn 501
Cambridge 492
New York 426
Frankfurt am Main 425
Milan 404
Princeton 363
Jakarta 223
Nanjing 171
Lawrence 161
Jacksonville 153
Altamura 152
Moscow 148
Beijing 123
Council Bluffs 116
San Diego 103
Vienna 81
Nuremberg 76
London 75
Rome 75
Guangzhou 74
Hefei 63
Shenyang 61
Hebei 60
Andover 57
Shanghai 56
Toronto 56
Nanchang 55
Jinan 53
Seoul 50
São Paulo 50
Helsinki 46
Zhengzhou 36
Dong Ket 35
Los Angeles 35
Boardman 33
Tianjin 33
Chicago 32
Jiaxing 32
Madrid 31
Tokyo 31
Phoenix 30
Changsha 28
Norwalk 28
Hangzhou 26
Ottawa 26
Amsterdam 24
Ningbo 22
Munich 21
San Francisco 21
The Dalles 21
Buenos Aires 19
Belo Horizonte 17
Brussels 17
Castano Primo 17
Copenhagen 15
Dallas 13
Groningen 13
Kunming 13
Modena 13
Upper Marlboro 13
Verona 13
Washington 13
Wuhan 13
Zurich 13
Atlanta 12
Boston 12
Central 12
Florence 12
Hyderabad 12
Lappeenranta 12
Pavia 12
Pune 12
Silver Spring 12
Sydney 12
Bogotá 11
Bologna 11
Clearwater 11
Edmonton 11
Genoa 11
Lisbon 11
Mexico City 11
Naples 11
Athens 10
Falls Church 10
Huizen 10
Montreal 10
Padova 10
Redmond 10
Totale 17.205
Nome #
Indications and utility of cardiac genetic testing in athletes 445
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 385
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 355
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 344
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 316
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 302
Genetic mechanisms of critical illness in COVID-19 273
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 266
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 263
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 238
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 233
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 233
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 231
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 215
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 210
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 207
Mapping the human genetic architecture of COVID-19 207
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 203
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 202
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 198
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 198
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 198
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 176
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 169
Infanticide vs. inherited cardiac arrhythmias. 161
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 159
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 152
The ICD for the long QT syndrome: which indications, complications, and results? 151
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 149
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 147
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 147
Inherited cardiac arrhythmia syndrome. Role of potassium channels 144
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 144
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 143
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 143
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 142
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents 142
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 142
The Long QT Syndrome 141
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 138
Prevalence of the congenital long-qt syndrome 138
Brugada and Long QT Syndrome are two different diseases: True or False? 138
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 138
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 138
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 138
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 137
The genetics underlying acquired long QT syndrome: Impact for genetic screening 137
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 137
Cardiac potassium channel dysfunction in sudden infant death syndrome 137
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 137
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 136
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 136
Neuroimmune crosstalk in the pathophysiology of hypertension. 136
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 135
Long and Short QT syndromes. 135
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 135
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 134
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 134
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 133
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 132
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 132
Long and Short QT Syndromes 132
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients 131
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 131
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 131
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 131
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 130
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 130
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 130
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 129
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis 128
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions -A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology 127
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 127
Genetic of adult and fetal forms of Long QT Syndrome. 127
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 127
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 126
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 126
Congenital long QT syndrome 126
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 123
Cardiac sodium channel dysfunction in sudden infant death syndrome 123
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 122
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant 122
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 122
QTc behavior during exercise and genetic testing for the long-QT syndrome 121
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia 120
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 118
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome 118
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 117
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 117
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients 115
All LQT3 patients need an ICD. True or false? 115
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome 115
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: Validation of the 2013 diagnostic criteria 114
Ion channel diseases in children: Manifestations and management 114
When genetic screening for your patient with long QT syndrome comes back negative, don't always take a no for a no 114
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel 113
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk 113
Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry 112
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization 111
Sudden cardiac death in infancy: Focus on prolonged repolarization 111
Totale 16.024
Categoria #
all - tutte 109.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 0 0 0 0 0 0 0 0 83
2020/20212.916 68 202 293 297 168 264 543 300 182 231 181 187
2021/20221.909 153 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20243.086 124 162 157 89 420 709 509 107 300 92 79 338
2024/20258.269 466 1.208 617 332 622 347 456 358 1.061 1.102 673 1.027
Totale 26.239